Astrana Health (ASTH) Gains from Sales and Divestitures (2024 - 2025)
Astrana Health recorded quarterly Gains from Sales and Divestitures of $363061.0 in Q4 2025, up 364.24% quarter-over-quarter from $78206.0 in Q4 2024, and up 364.24% year-over-year from $78206.0 in Q4 2024.
Astrana Health's Gains from Sales and Divestitures history runs 2 years deep, the most recent figure standing at $363061.0 for Q4 2025.
- In Q4 2025, Gains from Sales and Divestitures rose 364.24% year-over-year to $363061.0; the TTM figure through Dec 2025 stood at $363061.0 (up 364.24% YoY), while the FY2025 annual figure was $363061.0, up 364.24% from the prior year.
- Gains from Sales and Divestitures came in at $363061.0 for Q4 2025 at Astrana Health, up from $78206.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $363061.0 in Q4 2025 to a low of $78206.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | Astrana Health | 1.84 Bn | 1.37 Bn | 105.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 363,061.00 |
| Dec 31, 2025 | 363,061.00 |
| Dec 31, 2024 | 78,206.00 |
| Dec 31, 2024 | 78,206.00 |